Diagnostics

Comprehensive infectious disease screening within inpatient substance use disorder programs can increase uptake of testing and facilitate low-barrier delivery of preventive and therapeutic treatment. More

Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT study More

Testing PWID for HCV every 6 months could reduce HCV prevalence by up to 45%, incidence by 37%, and HCV-related deaths by 42% over 10 years. More

Study findings underscore the cost-effectiveness of more frequent hepatitis C testing among people who inject drugs, compared to less frequent or no testing at all. More

Shortening the OraQuick HCV antibody test from 20 to 5 minutes reduced false positives and unnecessary follow-up RNA testing, but detected fewer viremic individuals. More

A study evaluated the acceptability of dried blood spot and point-of-care testing among people at risk of HCV infection and examined the circumstances in which such testing is most preferred. More

A study explored operator experiences, including the challenges and enablers, of implementing point-of-care testing as part of a National Point-of-Care Testing Program. More

Whereas affordable HCV self-testing can improve HCV screening, the price and availability of virologic testing, required to confirm HCV diagnosis prior to treatment, remains a major obstacle to HCV elimination in LMICs and must be urgently addressed. More

A study assessed the usability and acceptability of HCV antibody self-testing in a high HCV prevalence informal settlement in Karachi, Pakistan. More

An article explores a hepatitis C testing program implemented at a remand prison, highlighting the role of oral swabs and peer involvement in increasing testing rates. More